[Adjuvant therapy of colon cancer. State of the art and future perspectives].
Barni
S
S
Cascinu
S
S
Foa
P
P
Frontini
L
L
Labianca
R
R
Luporini
G
G
Mandalà
M
M
Martignoni
G
G
Pancera
G
G
Sobrero
A
A
Zaniboni
A
A
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D002277:Carcinoma / Q000188:drug therapy* / Q000473:pathology / Q000628:therapy; D017024:Chemotherapy, Adjuvant; D002986:Clinical Trials as Topic; D003110:Colonic Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000628:therapy; D005472:Fluorouracil / Q000627:therapeutic use; D005492:Folic Acid / Q000627:therapeutic use; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D002955:Leucovorin / Q000627:therapeutic use; D007978:Levamisole / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D009367:Neoplasm Staging; D016019:Survival Analysis; D016896:Treatment Outcome
D007155:Immunologic Factors; D007978:Levamisole; D005492:Folic Acid; D002955:Leucovorin; D005472:Fluorouracil; D008727:Methotrexate
Trattamento adiuvante del carcinoma del colon. Stato dell'arte e prospettive future.